BioSpace News Archive

Biocept, Inc. (NASDAQ: BIOC) (“Biocept” or the “Company”), today announced that it has entered into a securities purchase agreement with several institutional investors.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that that the European Medicines Agency (EMA) has granted both PRIME (PRIority MEdicines) and Advanced Therapy Medicinal Product (ATMP) designations to the company’s adeno-associated virus (AAV)-RPGR gene therapy product

PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Michel Vounatsos has been elected to its board of directors, effective March 1, 2020.

AnaptysBio today reported operating results for the fourth quarter and year ended December 31, 2019 and provided pipeline updates.

Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the food safety assets of Australia-based Cell BioSciences — a major supplier of food safety and industrial microbiology products.

Yuyu Pharma (COO Robert Wonsang Yu, KRX 000220) announced today a review of its compliance policies and procedures with the support of the law firm, Kim & Chang.

Fostering understanding of the unique needs of individuals with bleeding disorders

BioPharma has today decided to donate its World Health Organization (WHO) approved facility for coronavirus COVID-19 vaccine research and treatments.

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, will report fourth quarter and 2019 financial results following the close of U.S. financial markets on Mar. 18 and host a conference call at 1:30 p.m. PT/4:30 p.m. ET to discuss the results and provide operational updates.

Artificial intelligence and advanced visualization technology innovator TeraRecon has been awarded two first-of-its-kind technology patents from the U.S. Patent and Trademark Office.